v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Total revenues $ 70,143 $ 138,590 $ 104,754
Costs and operating expenses:      
Cost of product revenue 12,809 38,033 22,209
Research and development 58,885 80,099 55,919
Selling, general and administrative 53,250 52,172 49,323
Restructuring charges 3,284 3,167 0
Asset impairment and other charges 9,984 0 0
Total costs and operating expenses 138,212 173,471 127,451
Loss from operations (68,069) (34,881) (22,697)
Interest income 4,172 1,441 459
Other income (expense), net ($0, $208 and $983 from a related party) (12,274) 124 1,148
Loss before income taxes (76,171) (33,316) (21,090)
Provision for income taxes 69 276 189
Net loss $ (76,240) $ (33,592) $ (21,279)
Net loss per share, basic (in dollars per share) $ (1.12) $ (0.51) $ (0.33)
Net loss per share, diluted (in dollars per share) $ (1.12) $ (0.51) $ (0.33)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 68,131 65,344 64,568
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 68,131 65,344 64,568
Product revenue ($0, $514 and $0 from a related party)      
Revenues:      
Total revenues $ 42,906 $ 116,676 $ 70,657
Research and development revenue ($0, $1,245 and $1,955 from a related party)      
Revenues:      
Total revenues $ 27,237 $ 21,914 $ 34,097

Source